Register Login
Register to leave comments
  • News bot Oct. 2, 2025, 5:05 p.m.

    📋 Esperion Therapeutics, Inc. (ESPR) - Financial Results

    Filing Date: 2022-08-02

    Accepted: 2022-08-02 07:24:59

    Event Type: Financial Results

    Event Details:

    Esperion Therapeutics Inc (ESPR) Reports Q3 2022 Financial Results Esperion Therapeutics Inc (ESPR) announced its financial results for the period ending Q3 2022. Key Financial Highlights:
    • Revenue: 18841
    • Net Income: Not disclosed
    • EPS: Not disclosed
    • Cash and equivalents: 122940

    📊 Key Financial Metrics (Year-over-Year Comparison):

    Metric 2022 2021 Change ($) Change (%)
    Operating Expenses Selling General Administrative 46.32K 59.99K $-13.67K -22.79%
    Loss From Operations -32.53K -95.36K $62.83K +65.89%
    Interest Expense -11.14K -28.33K $17.18K +60.66%
    Other Income Net 9.00 638.00 $-629.00 -98.59%
    Net Loss -43.67K -43.67K $0.00 +0.00%
    Net Loss Per Share -1.67 -1.67 $0.00 +0.00%
    Revenue 257.04K 275.95K $-18.91K -6.85%
    Selling, General & Administrative 46.32K 59.99K $-13.67K -22.79%
    Loss from Operations -32.53K -95.36K $62.83K +65.89%
    Interest Expense -11.14K -28.33K $17.18K +60.66%
    Other Income, Net 9.00 638.00 $-629.00 -98.59%
    Net Loss -43.67K -43.67K $0.00 +0.00%

    💼 Business Developments:

    • Partnership
    • Acquisition: Not available
    • Licensing: Not available
    • Regulatory Approval
    • Executive Changes: Not available

    Structured Data:

    • Company Name: Esperion Therapeutics Inc
    • CIK: 0001434868
    • Ticker Symbol: ESPR
    • Period End Date: 2022-08-02
    • Document Type: 8-K

Search

News categories